Loading company
Dyadic International Inc.
DYAI · Nasdaq · ·
Next earnings: November 11, 2026
$0.47-2.0%Sep 29 close
- 1M
- -23.6%
- 6M
- -35.7%
- 1Y
- -60.3%
- 5Y
- -92.1%
DYAI · Nasdaq · ·
Next earnings: November 11, 2026
$0.47-2.0%Sep 29 close
Dyadic International Inc. is scheduled to report next on November 11, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $961.1K | $966.6K | -0.57% |
| Profit | -$2.1M | -$1.8M | -18.40% |
| Profit per share | -$0.06 | -$0.06 | 0.00% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Dyadic International Inc. has no earnings call transcript available.
Releases land after the close or before the open, so the move is the session that follows.
Dyadic Applied BioSolutions is a global biotechnology company that uses its proprietary microbial platforms to produce recombinant proteins that are sold or licensed to partners across the life sciences, food and nutrition, and bio-industrial markets. These high-quality proteins are designed to enable customers to develop more efficient, scalable, and sustainable products. Dyadic’s Dapibus™ and C1 expression systems support flexible, cost-effective manufacturing, and are the foundation of a growing portfolio of commercial and partnered programs.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Dyadic International Inc.’s Item 2.02 8-K filed August 12, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.